| |
| |
|
| Insider
Information: |
Rock Springs Capital Llc |
| Relationship: |
10% Owner |
| City: |
Baltimore |
| State: |
MD |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
3,279,081 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$603,671 |
|
|
| Total
Shares |
3,279,081 |
|
|
| Total
Value |
$603,671 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Q32 Bio Inc |
QTTB |
10% Owner |
2018-04-02 |
0 |
2018-04-02 |
645,845 |
Premium* |
|
|
Enliven Therapeutics Ord Shs |
ELVN |
10% Owner |
2020-03-16 |
0 |
2020-03-16 |
523,411 |
Premium* |
|
|
Inozyme Pharma, Inc. |
INZY |
10% Owner |
2020-07-28 |
0 |
2020-07-28 |
1,067,884 |
Premium* |
|
|
Atea Pharmaceuticals, Inc. |
AVIR |
10% Owner |
2020-11-03 |
0 |
2020-11-03 |
289,695 |
Premium* |
|
|
Verve Therapeutics, Inc. |
VERV |
10% Owner |
2021-06-21 |
0 |
2021-06-21 |
152,926 |
Premium* |
|
|
Theseus Pharmaceuticals, Inc. |
THRX |
10% Owner |
2021-10-12 |
0 |
2021-10-12 |
599,320 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
12 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| THRX |
Theseus Pharmaceuticals, ... |
10% Owner |
– – • |
2021-10-12 |
4 |
B |
$16.00 |
$4,000,000 |
I/I |
250,000 |
599,320 |
1.5 |
- |
|
| THRX |
Theseus Pharmaceuticals, ... |
10% Owner |
– – • |
2021-10-12 |
4 |
A |
$0.00 |
$0 |
I/I |
436,649 |
87,329 |
0 |
- |
|
| VERV |
Verve Therapeutics, Inc. |
10% Owner |
– – • |
2021-06-21 |
4 |
A |
$0.00 |
$0 |
I/I |
709,224 |
152,926 |
0 |
- |
|
| VERV |
Verve Therapeutics, Inc. |
10% Owner |
– – • |
2021-06-21 |
4 |
B |
$19.00 |
$7,030,000 |
I/I |
370,000 |
926,298 |
1.5 |
- |
|
| AVIR |
Atea Pharmaceuticals, Inc... |
10% Owner |
– – • |
2020-11-03 |
4 |
B |
$24.00 |
$6,000,000 |
I/I |
250,000 |
289,695 |
1.5 |
- |
|
| AVIR |
Atea Pharmaceuticals, Inc... |
10% Owner |
– – • |
2020-11-03 |
4 |
A |
$0.00 |
$0 |
I/I |
1,694,419 |
282,403 |
0 |
- |
|
| INZY |
Inozyme Pharma, Inc. |
10% Owner |
– – • |
2020-07-28 |
4 |
B |
$16.00 |
$9,600,000 |
I/I |
600,000 |
1,067,884 |
1.5 |
- |
|
| INZY |
Inozyme Pharma, Inc. |
10% Owner |
– – • |
2020-07-28 |
4 |
A |
$0.00 |
$0 |
I/I |
467,884 |
467,884 |
0 |
- |
|
| ELVN |
Enliven Therapeutics Ord ... |
10% Owner |
– – • |
2020-03-16 |
4 |
B |
$16.00 |
$4,000,000 |
I/I |
250,000 |
523,411 |
1.5 |
- |
|
| ELVN |
Enliven Therapeutics Ord ... |
10% Owner |
– – • |
2020-03-16 |
4 |
A |
$0.00 |
$0 |
I/I |
273,411 |
273,411 |
0 |
- |
|
| QTTB |
Q32 Bio Inc |
10% Owner |
– – • |
2018-04-02 |
4 |
B |
$16.00 |
$4,000,000 |
I/I |
250,000 |
645,845 |
1.5 |
- |
|
| QTTB |
Q32 Bio Inc |
10% Owner |
– – • |
2018-04-02 |
4 |
A |
$0.00 |
$0 |
I/I |
395,845 |
395,845 |
0 |
- |
|
12 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
